Nexium safe for children
This article was originally published in The Tan Sheet
Executive Summary
FDA approves the use of AstraZeneca's prescription proton pump inhibitor Nexium (esomeprazole) for short-term treatment of children 1 to 11 years old for gastroesophageal reflux disease, the agency announces Feb. 28. Providers now can prescribe 10 mg to 20 mg daily doses for children 1 to 11 years old - half of the approved range for 12- to 17-year-olds, FDA says. The agency granted the approval after pediatric safety and pharmacokinetic studies revealed Nexium helped heal esophageal erosions after eight weeks of treatment...